» Articles » PMID: 17350460

Loss of Heterozygosity and Microsatellite Instability on Chromosome Arm 10q in Neuroblastoma

Overview
Date 2007 Mar 14
PMID 17350460
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor suppressor genes can be inactivated by various mechanisms, including promoter hypermethylation and loss of heterozygosity. We screened the 10q locus for loss of heterozygosity and the promoter methylation status of PTEN, MGMT, MXI1, and FGFR2 in neuroblastic tumors and neuroblastoma cell lines. Expression of these genes in cell lines was analyzed with reverse transcriptase-polymerase chain reaction. Loss of heterozygosity at 10q was detected in 18% of tumors and microsatellite instability in 14%. Promoter hypermethylation of MGMT appeared in 8% of tumors and 25% of cell lines. Correlation between methylation status and lack of expression was evident for PTEN, FGFR2, and MXI1 and was less clear for MGMT. No associations between these alterations and MYCN amplification, 1p deletion, or aggressive tumor histology could be demonstrated, singly or in combination. These data suggest that 10q alterations might be implicated in the development of a small number of neuroblastomas.

Citing Articles

Normal and Neoplastic Growth Suppression by the Extended Myc Network.

Prochownik E, Wang H Cells. 2022; 11(4).

PMID: 35203395 PMC: 8870482. DOI: 10.3390/cells11040747.


MYCN in Neuroblastoma: "Old Wine into New Wineskins".

Braoudaki M, Hatziagapiou K, Zaravinos A, Lambrou G Diseases. 2021; 9(4).

PMID: 34842635 PMC: 8628738. DOI: 10.3390/diseases9040078.


FGFR2 loss sensitizes MYCN-amplified neuroblastoma CHP134 cells to CHK1 inhibitor-induced apoptosis.

Ando K, Ohira M, Takada I, Cazares-Ordonez V, Suenaga Y, Nagase H Cancer Sci. 2021; 113(2):587-596.

PMID: 34807483 PMC: 8819351. DOI: 10.1111/cas.15205.


Systematic review of the receptor tyrosine kinase superfamily in neuroblastoma pathophysiology.

Rozen E, Shohet J Cancer Metastasis Rev. 2021; 41(1):33-52.

PMID: 34716856 PMC: 8924100. DOI: 10.1007/s10555-021-10001-7.


Chromosome 10 abnormality predicts prognosis of neuroblastoma patients with bone marrow metastasis.

Jiang C, Xu X, Jian B, Zhang X, Yue Z, Guo W Ital J Pediatr. 2021; 47(1):134.

PMID: 34108028 PMC: 8190999. DOI: 10.1186/s13052-021-01085-6.